Feed / LRMR

Larimar Therapeutics, Inc.

LRMR

Healthcare · 4.19 +12.5% today

Participation confirmed · construction unavailableMarket checked 20 Aug, 09:30 GMT-4

Jodie situation report

Larimar Therapeutics, Inc.'s move is being confirmed by its market group.

No new filing conclusion is available. 14 of 18 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 5 directly disclosed connections are confirming.

Company+12.5% todayVolume comparison unavailable
Market group14 of 18 activeBiotech Rare Diseases · active
Disclosed network0 of 5 confirmingNo filing-linked name is confirming now
What would change this read
  • At least 12 of 18 members remain active in the next snapshot.
  • Capital-flow agreement rises above 55%.
  • A filing-linked outsider such as ROIV begins moving with the group.

Invalidation: The live read weakens if participation falls to 6 of 18 members or fewer.

Watch this read

Who this business touches

The relationships behind LRMR

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Depends on

DSGNDesign Therapeutics, Inc.competitorMar 19, 2026

Other competitors currently developing therapeutics to treat FA include, but are not limited to Design Therapeutics, Lexeo Therapeutics, Neurocrine Biosciences/Voyager Therapeutics, Solid Biosciences and PTC Therapeutics ("PTC").

LXEOFiling-linked namecompetitorMar 19, 2026

Other competitors currently developing therapeutics to treat FA include, but are not limited to Design Therapeutics, Lexeo Therapeutics, Neurocrine Biosciences/Voyager Therapeutics, Solid Biosciences and PTC Therapeutics ("PTC").

NBIXNeurocrine Biosciences, Inc.competitorMar 19, 2026

Other competitors currently developing therapeutics to treat FA include, but are not limited to Design Therapeutics, Lexeo Therapeutics, Neurocrine Biosciences/Voyager Therapeutics, Solid Biosciences and PTC Therapeutics ("PTC").

Filing peers

Companies whose filings use similar operating language.

Open the three relationships above to see Jodie’s filing proof. Pro unlocks 4 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →

What is moving around it

Live connections

LRMR is currently a Participant in the organic co-movement group Biotech Rare Diseases. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.